TEDA BIOMEDICAL (08189): Zhao Zhiyou resigns from the position of independent supervisor.

12/02/2025

Teda Biology (08189) announced that Zhao Zhiyou, due to being busy with other matters, no longer has sufficient time to dedicate to the company's business.

TEDA BIOMEDICAL (08189) announced that Zhao Zhiyou has resigned from his position as an independent supervisor of the company, with the resignation effective from February 12, 2025, due to his busy schedule which no longer allows him to devote ample time to the company's business.

JP Morgan is optimistic about the potential of the CRISPR gene editing pipeline and has initiated coverage with an "overweight" rating and a target price of $70 USD.

GMTEight List of A-share restricted sales and lifting restrictions | September 19th

Highlights of the morning meeting of securities firms | Huawei clarifies the iteration plan of the Ascend AI chip, and continues to be optimistic about domestic computing power.

JP Morgan is optimistic about the potential of the CRISPR gene editing pipeline and has initiated coverage with an "overweight" rating and a target price of $70 USD.

GMTEight List of A-share restricted sales and lifting restrictions | September 19th

Highlights of the morning meeting of securities firms | Huawei clarifies the iteration plan of the Ascend AI chip, and continues to be optimistic about domestic computing power.